OBJECTIVE: Activation of signal transducer and activator of transcription 3 (STAT3) was reported to be correlated with myocardial protection against ischemia/reperfusion (I/R) injury in ischemic preconditioning. Here, we tested the causality between STAT3 activity and cardioprotection. We also addressed the molecular mechanism for its cardioprotection. METHODS AND RESULTS: Cardiac-specific transgenic mice expressing constitutively active STAT3 (TG) were generated and exposed to I/R injury. TG hearts exhibited infarcts that reduced by 60.3% in size, compared with nontransgenic littermates (NTG). By measuring dichlorofluorescein (DCF) and 8-isoprostane, reactive-oxygen-species (ROS)-induced metabolites, it was revealed that ROS were generated to lesser extent in TG hearts than in NTG in response to I/R stress. In parallel, ROS scavengers, metallothionein1 (MT1), and metallothionein2 (MT2) were markedly up-regulated in TG hearts. Finally, homozygous deletion of the MT1 and MT2 genes abrogated cardioprotective effect of STAT3 against I/R injury with the cancellation of its ROS-scavenging effects. CONCLUSIONS: Activation of STAT3 protects myocardium from I/R injury in vivo. STAT3 mediates cardioprotection at least partially through MT1 and 2. STAT3 is a potential therapeutic target for I/R injury.
OBJECTIVE: Activation of signal transducer and activator of transcription 3 (STAT3) was reported to be correlated with myocardial protection against ischemia/reperfusion (I/R) injury in ischemic preconditioning. Here, we tested the causality between STAT3 activity and cardioprotection. We also addressed the molecular mechanism for its cardioprotection. METHODS AND RESULTS: Cardiac-specific transgenic mice expressing constitutively active STAT3 (TG) were generated and exposed to I/R injury. TG hearts exhibited infarcts that reduced by 60.3% in size, compared with nontransgenic littermates (NTG). By measuring dichlorofluorescein (DCF) and 8-isoprostane, reactive-oxygen-species (ROS)-induced metabolites, it was revealed that ROS were generated to lesser extent in TG hearts than in NTG in response to I/R stress. In parallel, ROS scavengers, metallothionein1 (MT1), and metallothionein2 (MT2) were markedly up-regulated in TG hearts. Finally, homozygous deletion of the MT1 and MT2 genes abrogated cardioprotective effect of STAT3 against I/R injury with the cancellation of its ROS-scavenging effects. CONCLUSIONS: Activation of STAT3 protects myocardium from I/R injury in vivo. STAT3 mediates cardioprotection at least partially through MT1 and 2. STAT3 is a potential therapeutic target for I/R injury.
Authors: Daniel E Conway; Sungmun Lee; Suzanne G Eskin; Ankit K Shah; Hanjoong Jo; Larry V McIntire Journal: Am J Physiol Cell Physiol Date: 2010-09-22 Impact factor: 4.249
Authors: Holger Lörchner; Jochen Pöling; Praveen Gajawada; Yunlong Hou; Viktoria Polyakova; Sawa Kostin; Juan M Adrian-Segarra; Thomas Boettger; Astrid Wietelmann; Henning Warnecke; Manfred Richter; Thomas Kubin; Thomas Braun Journal: Nat Med Date: 2015-03-09 Impact factor: 53.440
Authors: Karol Szczepanek; Qun Chen; Marta Derecka; Fadi N Salloum; Qifang Zhang; Magdalena Szelag; Joanna Cichy; Rakesh C Kukreja; Jozef Dulak; Edward J Lesnefsky; Andrew C Larner Journal: J Biol Chem Date: 2011-06-29 Impact factor: 5.157
Authors: K Schaeferhoff; S Michalakis; N Tanimoto; M D Fischer; E Becirovic; S C Beck; G Huber; N Rieger; O Riess; B Wissinger; M Biel; M W Seeliger; M Bonin Journal: Cell Mol Life Sci Date: 2010-05-14 Impact factor: 9.261